![Michael Schultz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Michael K.
Schultz is a Chief Science Officer at Viewpoint Molecular Targeting, Inc. and a Chief Science Officer at Perspective Therapeutics, Inc. Dr. Schultz was previously employed as a Principal by National Institute of Health Policy and an Associate Professor by University of Iowa.
| Companies | Position | Start |
|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Founder | 01/01/2008 |
| Companies | Position | End |
|---|---|---|
National Institute of Health Policy | Corporate Officer/Principal | - |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institute of Health Policy | |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Perspective Therapeutics, Inc.
 Perspective Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical technology devices | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
